Stay updated with breaking news from Genomics Systems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Research Analysts’ upgrades for Saturday, June 4th: Agilent Technologies (NYSE:A) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating. Amarin (NASDAQ:AMRN) was upgraded by analysts at StockNews.com from a sell rating to a hold rating. Blucora (NASDAQ:BCOR) was upgraded by analysts at StockNews.com from a hold rating to a buy […]
Analysts’ upgrades for Saturday, June 4th: Agilent Technologies (NYSE:A) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating. Amarin (NASDAQ:AMRN) was upgraded by analysts at StockNews.com from a sell rating to a hold rating. Blucora (NASDAQ:BCOR) was upgraded by analysts at StockNews.com from a hold rating to a buy rating. […]
Equities Research Analysts’ downgrades for Friday, June 3rd: Ansell (OTCMKTS:ANSLY) was downgraded by analysts at Credit Suisse Group AG from a neutral rating to an underperform rating. AON (NYSE:AON) was downgraded by analysts at Morgan Stanley from an equal weight rating to an underweight rating. Morgan Stanley currently has $250.00 target price on the stock, […]
Singular Genomics Systems (NASDAQ:OMIC – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Friday, Zacks.com reports. According to Zacks, “Singular Genomics Systems Inc. is a life science technology company. It focused on delivering genomic technologies for the advancement of science and medicine. […]
Singular Genomics Systems (NASDAQ:OMIC – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it contrast to its rivals? We will compare Singular Genomics Systems to similar companies based on the strength of its earnings, analyst recommendations, dividends, valuation, institutional ownership, risk and profitability. Insider and Institutional Ownership […]